PIERIS PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pieris Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2013 to Q3 2024.
  • Pieris Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.89M, a 73.1% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$16M, a 43.1% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$24.5M, a 26.2% increase from 2022.
  • Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.3M, a 27.2% increase from 2021.
  • Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$45.7M, a 22.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$16M -$2.89M +$7.87M +73.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$23.8M -$3.59M -$7.57M -190% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$16.3M -$4.89M +$8.29M +62.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$24.5M -$4.58M +$3.52M +43.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$28.1M -$10.8M -$1.02M -10.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$27M $3.98M +$14.3M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$41.4M -$13.2M -$8.08M -158% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$33.3M -$8.1M +$1.43M +15% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$34.7M -$9.74M +$6.8M +41.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$41.5M -$10.3M +$5.16M +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$46.7M -$5.1M -$929K -22.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$45.7M -$9.53M +$4.87M +33.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$50.6M -$16.5M -$2.25M -15.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$48.4M -$15.5M -$10.5M -213% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$37.8M -$4.17M -$575K -16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$37.2M -$14.4M -$13.6M -1768% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 -$23.6M -$14.3M -$11.7M -451% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$11.9M -$4.95M +$6.81M +57.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$18.7M -$3.6M +$6.75M +65.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$25.5M -$771K +$10.9M +93.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$36.4M -$2.59M +$3.56M +57.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$39.9M -$11.8M -$11.6M -5692% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$28.4M -$10.3M -$1.63M -18.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$26.8M -$11.7M -$19.2M -256% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$7.58M -$6.15M +$906K +12.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$8.49M -$203K +$9.88M +98% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$18.4M -$8.71M -$720K -9.01% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$17.6M $7.49M +$14M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$31.7M -$7.06M -$863K -13.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$30.8M -$10.1M -$4.2M -71.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$26.6M -$7.99M -$3.83M -92.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$22.8M -$6.56M -$3.66M -126% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$19.1M -$6.2M -$2.27M -58% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$16.9M -$5.88M -$2.35M -66.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$14.5M -$4.16M -$456K -12.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$14.1M -$2.9M +$1.26M +30.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$15.3M -$3.92M -$1.9M -94% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$13.4M -$3.53M -$648K -22.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$12.8M -$3.7M -$2.92M -375% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$9.85M -$4.17M -$4.16M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$5.69M -$2.02M +$3.74M +64.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$9.43M -$2.88M Apr 4, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$780K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$2.2K* Oct 1, 2013 Dec 31, 2013 10-Q 2014-05-14
Q3 2013 -$5.76M Jul 1, 2013 Sep 30, 2013 10-Q/A 2014-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.